헬스케어 분야 인지 평가 및 교육 시장 규모, 점유율 및 동향 분석 보고서 : 평가별, 구성요소별, 용도별, 지역별, 부문별 예측(2024-2030년)

헬스케어 분야 인지 평가 및 교육 시장의 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면, 헬스케어 분야의 인지 평가 및 훈련 세계 시장 규모는 2030년까지 261억 달러에 달할 것으로 예상됩니다.

이 시장은 2024-2030년간 연평균 복합 성장률(CAGR) 27.02%로 성장할 것으로 예상됩니다. 의료 전문가들은 기억 상실 및 기타 인지 기능 장애의 징후를 보이는 환자를 평가하기 위해 인지 기능 평가를 사용합니다. 이러한 평가는 파킨슨병, 뇌종양, 뇌졸중 관련 인지 장애를 포함한 다양한 질병을 선별하고 치매 발병 위험이 있는 환자를 식별하는 데 도움이 됩니다. 치매 환자 발생률 증가, 인지 건강에 대한 인식 증가, 기술적으로 진보된 인지 평가 및 훈련 도구는 여전히 성장의 주요 요인으로 작용하고 있습니다. 또한 임상시험 및 치매 연구에서 인지 기능 평가의 적용이 증가하고 있는 것도 시장 성장을 가속하는 요인입니다.

코로나19의 대유행은 응급실 방문이 감소하고 외래 진료 예약이 크게 지연되는 등 시장에 영향을 미쳤습니다. 또한 일대일 대화가 필요한 진료 서비스는 감염에 대한 우려로 인해 어려움을 겪었습니다. 시장 관계자들은 초기 단계에서 손실을 입었습니다. 그러나 원격의료와 인지기능 검사 및 교육용 온라인 플랫폼이 새로운 수익원을 창출하면서 이러한 손실을 일부 완화했습니다. 그 결과 원격(분산형) 임상시험, 재택 평가 등 첨단 기술이 전례 없는 속도로 채택되고 있습니다.

기술에 익숙한 세대의 두뇌 평가 및 훈련에 대한 수요와 인지 솔루션 시장의 확대는 인지 평가 및 훈련 분야의 부상을 촉진하고 있습니다. 기술의 발전으로 두뇌 훈련 활동은 스마트폰, 태블릿, 컴퓨터, 그리고 최근에는 게임기를 통한 컴퓨터화 된 훈련에 꾸준히 도입되고 있습니다. 일부 두뇌 훈련은 특정 인지 능력에 초점을 맞추는 반면, 다른 두뇌 훈련은 보다 종합적이고 상호 연관성이 있습니다. 인지 훈련의 다른 활동에는 조작기, 카드 놀이와 같은 추가 지원, 신체 활동, 종이와 연필이 필요한 과제, 컴퓨터를 이용한 운동 및 기타 훈련 기술이 포함됩니다.

헬스케어 분야 인지 평가 및 교육 시장 보고서 하이라이트:

평가에 따르면, 펜과 종이로 된 평가 분야는 접근성, 편리성, 경제성으로 인해 2023년 47% 이상의 매출 점유율을 차지하며 시장을 장악했습니다. 원격 의료 도입 증가로 인해 호스트형 평가 분야는 예측 기간 동안 28% 이상의 CAGR을 기록할 것으로 예상됩니다.

구성요소별로는 서비스 부문이 2023년 50.0% 이상의 매출 점유율을 차지할 것으로 예상됩니다. 이는 최고 수준의 표준을 준수하면서 가장 효율적인 방식으로 스케일을 구현하기 위한 교육 및 지원, 평가자 자격 인증, 교육 및 관리와 관련된 컨설팅에 대한 수요가 증가하고 있기 때문입니다.

용도별로는 임상시험 분야가 2023년 42.0% 이상의 매출 점유율로 시장을 독점하고 있으며, 예측 기간 동안에도 그 지위를 유지할 것으로 보입니다.

북미는 인지 질환 치료와 관련된 사회적 인식이 높아지면서 2023년 37.0% 이상의 가장 큰 매출 점유율을 차지할 것으로 예상됩니다. 이 지역에서는 인지 장애에 취약한 고령화 인구가 빠르게 증가하고 있으며, 이에 따라 임상시험 및 연구를 위한 정부 자금이 증가하고 있습니다.

아시아태평양은 인지 장애로 이어지는 스포츠 외상 발생률 증가, 노인 인구 증가, 빠르게 확장되는 의료 인프라, 정부 지원 증가로 인해 예측 기간 동안 가장 빠른 CAGR을 기록할 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 헬스케어 시장 변수, 동향, 범위 인지 평가와 트레이닝

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/부수 시장 전망
• 보급 및 성장 전망 매핑
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 헬스케어 시장 분석 툴 인지 평가와 트레이닝
  • 업계 분석 - Porter의 Five Forces 분석
  • PESTEL 분석

제4장 헬스케어 분야 인지 평가 및 트레이닝 : 평가 추정·동향 분석

• 헬스케어 분야 인지 평가 및 트레이닝 시장 : 중요 포인트
• 헬스케어 분야 인지 평가 및 트레이닝 시장 : 동향과 시장 점유율 분석, 2023년 & 2030년
• 생체인식 평가
• 펜 및 종이 기반 평가
• 호스트형 평가

제5장 헬스케어 분야 인지 평가 및 트레이닝 : 컴포넌트 추정·동향 분석

• 헬스케어 분야 인지 평가 및 트레이닝 시장 : 중요 포인트
• 헬스케어 분야 인지 평가 및 트레이닝 시장 : 동향과 시장 점유율 분석, 2023년 & 2030년
• 솔루션
  • 평가
  • 데이터 분석 및 보고서 작성
  • 데이터 관리
  • 기타
• 서비스
  • 트레이닝 및 지원
  • 컨설팅

제6장 헬스케어 분야 인지 평가 및 트레이닝 : 용도 추정·동향 분석

• 헬스케어 분야 인지 평가 및 트레이닝 시장 : 중요 포인트
• 헬스케어 분야 인지 평가 및 트레이닝 시장 : 동향과 시장 점유율 분석, 2023년 & 2030년
• 임상시험
• 스크리닝 및 진단
• 뇌 트레이닝
• 학술 연구

제7장 헬스케어 분야 인지 평가 및 트레이닝 시장 : 지역 추정·동향 분석

• 지역별 전망
• 지역별 헬스케어 분야 인지 평가 및 트레이닝 시장 : 마켓플레이스에서의 중요 포인트
• 북미
  • 시장 추산·예측, 2018-2030년
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 스웨덴
  • 노르웨이
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 태국
  • 한국
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
• 중동 및 아프리카
  • 사우디아라비아
  • 남아프리카공화국
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 주요 시장 진출기업의 최근 동향과 영향 분석
• 시장 진출기업 분류
  • Cambridge Cognition Ltd.
  • CogniFit Inc
  • Cogstate Ltd
  • CNS Vital Signs, LLC
  • Brain Resource Company
  • WIRB-Copernicus Group
  • Quest Diagnostics Incorporated
  • Signant Health
  • Posit Science
  • Clario
  • Cognetivity Neurosciences

LSH 24.01.23

Cognitive Assessment And Training In Healthcare Market Growth & Trends:

The global cognitive assessment and training in healthcare market size is expected to reach USD 26.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 27.02% from 2024 to 2030. Healthcare professionals use cognitive assessment to evaluate patients who exhibit loss of memory or other signs of cognitive impairment. These assessments are helpful in screening for a variety of illnesses including Parkinson's disease, brain tumors, and stroke-related cognitive problems, and identifying patients who are at risk of developing dementia. Rise in incidence rates of dementia cases, increasing awareness regarding cognitive health, and technologically advanced cognitive assessments & training tools remain key factors for growth. Moreover, increased application of cognitive assessments in clinical trials and dementia research are also other factors driving growth of market.

The COVID-19 pandemic affected the market with a reduction in emergency visits and significantly delayed outpatient clinic appointments. In addition, consultation services that involve one-on-one interaction were hampered due to concerns about transmission. Market players suffered losses in the initial phase. However, telemedicine and online platforms for cognitive testing and training created new revenue streams to mitigate some of those losses. As a result, cutting-edge technologies such as remote (decentralized) clinical trials and home-based assessments have been adopted at an unprecedented rate.

Demand for brain assessment training through tech-savvy generation and expansion of market for cognitive solutions are both driving the rise of cognitive assessment and training sector. Due to advancement of technology, brain training activities have been steadily incorporated into computerized training on smartphones and tablets, computers, and more recently, gaming consoles. Some brain training regimens focus on particular cognitive skills, while others are more comprehensive and interconnected. Programs for cognitive training may include manipulatives; additional support, such as playing cards; physical activity; tasks requiring paper and pencil; computer-based exercises; and other training techniques.

Cognitive Assessment And Training In Healthcare Market Report Highlights:

• Based on assessment, pen and paper assessment segment dominated the market with a revenue share of more than 47 % in 2023, owing to easier availability, convenience, and affordability. The hosted assessment segment is expected to witness a CAGR of over 28% over the forecast period pertaining to increase in adoption of telemedicine
• Based on component, the services segment held a majority of revenue share of more than 50.0% in 2023 owing to increase in demand for training & support and consulting for rater qualification, training, and management that equip raters to administer scales in the most efficient manner while adhering to highest standards
• Based on application, the clinical trials segment dominated the market with a revenue share of over 42.0% in 2023 and is expected to retain its position during the forecast period
• North America held the largest revenue share of more than 37.0% in 2023 owing to rise in public awareness related to the treatments of cognitive illnesses. Due to rapidly aging population in the region, which is susceptible to cognitive disorders, government funding for clinical trials and research has increased
• Asia Pacific is anticipated to witness the fastest CAGR over the forecast period, due to increasing incidence of sports injuries & trauma leading to cognitive impairment, rising geriatric population, rapidly expanding healthcare infrastructure, and growing government backing

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Assessment
  • 1.1.2. Component
  • 1.1.3. Application
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Assessment outlook
  • 2.2.2. Component outlook
  • 2.2.3. Application outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Cognitive Assessment And Training In Healthcare Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
  • 3.3.2. Market restraint analysis
• 3.4. Cognitive Assessment And Training In Healthcare Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. Cognitive Assessment And Training In Healthcare: Assessment Estimates & Trend Analysis

• 4.1. Cognitive Assessment And Training In Healthcare Market: Key Takeaways
• 4.2. Cognitive Assessment And Training In Healthcare Market: Movement & Market Share Analysis, 2023 & 2030
• 4.3. Biometric Assessment
  • 4.3.1. Biometric assessment market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.4. Pen & Paper-based Assessment
  • 4.4.1. Pen & paper-based assessment market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Hosted Assessment
  • 4.5.1. Hosted assessment market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Cognitive Assessment And Training In Healthcare: Component Estimates & Trend Analysis

• 5.1. Cognitive Assessment And Training In Healthcare Market: Key Takeaways
• 5.2. Cognitive Assessment And Training In Healthcare Market: Movement & Market Share Analysis, 2023 & 2030
• 5.3. Solution
  • 5.3.1. Solution market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.3.2. Assessment
    • 5.3.2.1. Assessment market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.3.3. Data Analysis & Reporting
    • 5.3.3.1. Data analysis & reporting market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.3.4. Data Management
    • 5.3.4.1. Data management market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.3.5. Others
    • 5.3.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.4. Services
  • 5.4.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4.2. Training & Support
    • 5.4.2.1. Training & support market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4.3. Consulting
    • 5.4.3.1. Consulting market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Cognitive Assessment And Training In Healthcare: Application Estimates & Trend Analysis

• 6.1. Cognitive Assessment And Training In Healthcare Market: Key Takeaways
• 6.2. Cognitive Assessment And Training In Healthcare Market: Movement & Market Share Analysis, 2023 & 2030
• 6.3. Clinical Trials
  • 6.3.1. Clinical trials market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.4. Screening & Diagnostics
  • 6.4.1. Screening & diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Brain Training
  • 6.5.1. Brain training market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Academic Research
  • 6.6.1. Academic research market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Cognitive Assessment And Training In Healthcare Market: Regional Estimates & Trend Analysis

• 7.1. Regional Outlook
• 7.2. Cognitive Assessment And Training In Healthcare Market by Region: Key Marketplace Takeaways
• 7.3. North America
  • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. U.S. cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Canada cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key Country Dynamics
    • 7.4.1.2. Competitive Scenario
    • 7.4.1.3. Regulatory Framework
    • 7.4.1.4. UK cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. Germany cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. France cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. Italy cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Spain cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.6. Sweden
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Framework
    • 7.4.6.4. Sweden cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.7. Norway
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. Norway cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Framework
    • 7.4.8.4. Denmark cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key Country Dynamics
    • 7.5.1.2. Competitive Scenario
    • 7.5.1.3. Regulatory Framework
    • 7.5.1.4. Japan cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. China cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. India cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Australia cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Thailand
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Thailand cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. South Korea
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. South Korea cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key Country Dynamics
    • 7.6.1.2. Competitive Scenario
    • 7.6.1.3. Regulatory Framework
    • 7.6.1.4. Brazil cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Mexico
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Mexico cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Argentina cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. Saudi Arabia
    • 7.7.1.1. Key Country Dynamics
    • 7.7.1.2. Competitive Scenario
    • 7.7.1.3. Regulatory Framework
    • 7.7.1.4. Saudi Arabia cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. South Africa cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. UAE cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. Kuwait cognitive assessment and training in healthcare estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Market Participant Categorization
  • 8.2.1. Cambridge Cognition Ltd.
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. CogniFit Inc
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Cogstate Ltd
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. CNS Vital Signs, LLC
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Brain Resource Company
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. WIRB-Copernicus Group
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Quest Diagnostics Incorporated
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Signant Health
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Posit Science
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Clario
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. Cognetivity Neurosciences
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives